These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1314165)

  • 21. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein.
    Truant R; Xiao H; Ingles CJ; Greenblatt J
    J Biol Chem; 1993 Feb; 268(4):2284-7. PubMed ID: 8428901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus E1A proteins inhibit activation of transcription by p53.
    Steegenga WT; van Laar T; Riteco N; Mandarino A; Shvarts A; van der Eb AJ; Jochemsen AG
    Mol Cell Biol; 1996 May; 16(5):2101-9. PubMed ID: 8628276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
    Lin SR; Yang YC; Jung JH; Tsai JH
    DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
    Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
    Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system.
    Luo Y; Batalao A; Zhou H; Zhu L
    Biotechniques; 1997 Feb; 22(2):350-2. PubMed ID: 9043710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical and functional interaction between wild-type p53 and mdm2 proteins.
    Haines DS; Landers JE; Engle LJ; George DL
    Mol Cell Biol; 1994 Feb; 14(2):1171-8. PubMed ID: 8289798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription.
    Lee D; Kim JW; Seo T; Hwang SG; Choi EJ; Choe J
    J Biol Chem; 2002 Jun; 277(25):22330-7. PubMed ID: 11950834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
    Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
    Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SV40 T antigen abrogates p53-mediated transcriptional activity.
    Jiang D; Srinivasan A; Lozano G; Robbins PD
    Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
    Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.
    Aoyama N; Nagase T; Sawazaki T; Mizuguchi G; Nakagoshi H; Fujisawa JI; Yoshida M; Ishii S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5403-7. PubMed ID: 1535157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
    Horvath GC; Schubach WH
    Biochem Biophys Res Commun; 1993 Feb; 191(1):196-200. PubMed ID: 8383488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.
    Yew PR; Liu X; Berk AJ
    Genes Dev; 1994 Jan; 8(2):190-202. PubMed ID: 8299938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic activation of transcription by CBP and p53.
    Gu W; Shi XL; Roeder RG
    Nature; 1997 Jun; 387(6635):819-23. PubMed ID: 9194564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants.
    Deb D; Scian M; Roth KE; Li W; Keiger J; Chakraborti AS; Deb SP; Deb S
    Oncogene; 2002 Jan; 21(2):176-89. PubMed ID: 11803461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity.
    Fujii M; Tsuchiya H; Seiki M
    Oncogene; 1991 Dec; 6(12):2349-52. PubMed ID: 1766679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.